Distinct Cdk9-phosphatase switches act on elongation factor Spt5 at the beginning and end of the RNA polymerase II transcription cycle. Distinct Cdk9-phosphatase switches act on elongation factor Spt5 at the beginning and end of the RNA polymerase II transcription cycle
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA576357
下载链接
链接失效反馈官方服务:
资源简介:
The Pol II transcription cycle is ordered by CDKs and phosphatases. In fission yeast, Cdk9 phosphorylates carboxy-terminal repeats (CTRs) of Spt5 while inhibiting PP1 during elongation. Transcription past the cleavage and polyadenylation signal (CPS) coincides with PP1-dependent Spt5 dephosphorylation and leads to Pol II pausing with phosphorylated CTD-Ser2 (pSer2). Here we show this switch is conserved in humans: Cdk9 inhibition decreases phosphorylation of both PP1g and Spt5-Thr806 (pThr806), and induces pSer2 upstream of the CPS, whereas PP1 depletion increases pThr806. Moreover, in unperturbed cells, pThr806 is diminished in 3’-paused complexes where pSer2 is maximal. Cdk9 also phosphorylates Spt5 on Ser666, a PP1-refractory site between conserved KOW4 and KOW5 motifs; pSer666 increases upon promoter-proximal pause release and, in contrast to pThr806, persists beyond the CPS. We identify PP4—another target of inhibitory phosphorylation by Cdk9—as a pSer666 phosphatase. PP4 and PP1g are enriched at 5’ and 3’ ends of genes, respectively, consistent with pSer666 and pThr806 distributions. Therefore, distinct Cdk9-phosphatase switches operate on Spt5 at different steps in transcription. Overall design: ChIP-seq: Data represent nineteen different ChIP-seq experiments in human colon carcinoma (HCT116) cells, performed in biological replicates. There are raw and processed files (bigWig) for all biological replicates.
RNA聚合酶II(Pol II)的转录循环进程由细胞周期蛋白依赖性激酶(CDKs)与磷酸酶协同调控。在裂殖酵母中,Cdk9可磷酸化Spt5的羧基末端重复序列(carboxy-terminal repeats, CTRs),并在转录延伸过程中抑制蛋白磷酸酶1(PP1)。当转录穿过切割与多聚腺苷酸化信号(CPS)时,会伴随PP1依赖的Spt5去磷酸化,并使Pol II停留在带有磷酸化CTD丝氨酸2位点(pSer2)的状态。本研究证实该调控开关在人类中保守存在:抑制Cdk9可同时降低PP1γ及Spt5苏氨酸806位点磷酸化形式(pThr806)的水平,并诱导CPS上游区域出现pSer2信号;而敲低PP1则会提升pThr806的水平。此外,在未受干扰的细胞中,3’端暂停复合物内的pThr806水平会降低,而该区域恰是pSer2水平最高的位点。Cdk9还可磷酸化Spt5的丝氨酸666位点(Ser666),该位点位于保守的KOW4与KOW5基序之间,且为PP1不敏感位点;pSer666水平会在启动子近端暂停释放后升高,且与pThr806不同,其信号会持续至CPS下游区域。本研究鉴定出PP4作为pSer666的磷酸酶,而PP4亦是Cdk9抑制性磷酸化的另一作用靶标。PP4与PP1γ分别富集于基因的5’端与3’端,这与pSer666及pThr806的分布特征相符。因此,在转录的不同阶段,Cdk9与不同磷酸酶构成的调控开关可分别作用于Spt5。实验整体设计:染色质免疫共沉淀测序(ChIP-seq):本数据集包含19组针对人类结肠癌细胞(HCT116)的ChIP-seq实验数据,均设置生物学重复;所有生物学重复样本均提供原始测序文件与处理后的bigWig格式文件。
创建时间:
2019-10-08



